HIF-1α is further upregulated by GBM’s poor perfusion, as its atypical neovascularization contributes to a cycle that exacerbates its hypoxic environment and shields it from current therapies (39, 156, 157, 163). The gene discussed is HIF1A; the disease is glioblastoma.